Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mediterranean diet tested as lupus aid for kids

NCT ID NCT07555626

Disease control Sponsor: TC Erciyes University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a Mediterranean diet can improve gut bacteria, reduce disease activity, and boost nutrition in children with systemic lupus erythematosus (SLE). Sixty children with SLE and their healthy family members will take part. Participants will receive personalized nutrition counseling and be followed for 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mediterranean diet-based nutrition counseling
What this could lead to
If it works, this could point toward a simple dietary approach to help manage lupus symptoms and improve gut health in children.
What could go wrong
This is a small, early-stage trial with only 60 participants. Diet changes may not significantly affect disease activity, and results may not apply to all children with lupus.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Feb 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For participants with Systemic Lupus Erythematosus (SLE): * Diagnosis of SLE according to the SLICC classification criteria. * SLE diagnosis established at least 6 months prior to enrollment. For healthy controls (household members): * Living in the same household as participants with SLE. * Body mass index (BMI) within the normal range. Exclusion Criteria: For participants with SLE: * Presence of active infection. * Renal failure, or history of major trauma or surgery within the past 6 months. * Presence of additional chronic diseases other than SLE. * Use of antibiotics or probiotics within the past 4 weeks. * Following a specific or restrictive diet. * Illiteracy or cognitive impairment that may limit understanding of the intervention. For healthy controls (household members): * Presence of active infection * Presence of any chronic disease * Use of antibiotics or probiotics within the past 4 weeks * Following a specific or restrictive diet * Illiteracy or cognitive impairment that may limit understanding of study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Systemic lupus erythematosus (SLE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Systemic lupus erythematosus (SLE)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Erciyes University Mustafa Eraslan and Fevzi Mercan Children's Hospital

    Kayseri, Melikgazi, 38039, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.